20/20 GeneSystems
Latest round
- Series B
Last raised
- Nov 2018
Total raised
- Undisclosed
Investors
- 1
About 20/20 GeneSystems
20/20 GeneSystems Inc.20/20 GeneSystems Inc. focuses on developing advanced diagnostic solutions.20/20 BioLabs offers a suite of advanced, AI-powered laboratory-based blood tests for early cancer detection and prevention of chronic diseases. Their core product, OneTest™, uses a unique protein tumor marker approach to detect multiple cancers, including lung, pancreatic, ovarian, and liver cancers, at treatable stages. The tests facilitate at-home collection using painless capillary blood devices, addressing accessibility and comfort.20/20 BioLabs generates revenue through direct-to-consumer sales of its diagnostic tests, with OneTest™ priced at under USD 200, significantly lower than competing tests that exceed USD 1,000. Sales occur primarily online, supported by a user-friendly platform. The company also engages in partnerships with healthcare providers for bulk testing, broadening its client base.20/20 GeneSystems Inc. is focusing on launching new products, including a test for inflammation biomarkers, expected in Spring. The company plans to expand its reach into international markets, although specific locations have not been disclosed.
Who invested in 20/20 GeneSystems
1 investor across 1 round
See all investors in 20/20 GeneSystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 1, 2018
Amount
Undisclosed
Investors
Questions about 20/20 GeneSystems
Who invested in 20/20 GeneSystems?
20/20 GeneSystems has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 20/20 GeneSystems raised?
20/20 GeneSystems has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did 20/20 GeneSystems last raise money?
20/20 GeneSystems's most recent round on record is a Series B, in Nov 2018.
What does 20/20 GeneSystems do?
20/20 GeneSystems is a healthcare company.
Where is 20/20 GeneSystems headquartered?
20/20 GeneSystems is headquartered in Rockville, US.
Which VCs invest in companies like 20/20 GeneSystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at 20/20 GeneSystems's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like 20/20 GeneSystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.